Luís Herrera-Martínez

发表

High glucose burden inhibits EGFR/PI3K/AKT1/mTOR signaling pathway in cutaneous fibroblasts

J. Berlanga-Acosta, Y. Mendoza-Marí, Ariana García-Ojalvo, 2014 .

Growth hormone releasing peptide-6 (GHRP-6) and other related secretagogue synthetic peptides: A mine of medical potentialities for unmet medical needs

G. Nieto, J. Berlanga-Acosta, Ernesto López-Mola, 2016 .

Detrimental impact of acute and chronic glucose burden in wound-healing cells : fibroblasts , myofibroblasts and vascular precursor cells

P. López-Saura, J. Berlanga-Acosta, Marianela García-Siverio, 2012 .

Why can Epidermal Growth Factor ( EGF ) be used for the treatment of Diabetic Foot Ulcers ( DFU ) ?

W. Savigne, Díaz, Ernesto López-Mola, 2018 .

Medical Practice Confirms Clinical Trial Results of the Use of Intralesional Human Recombinant Epidermal Growth Factor in Advanced Diabetic FootUlcers

P. López-Saura, J. Fernández-Montequín, C. Valenzuela-Silva, 2013 .

Intralesional Human Recombinant Epidermal Growth Factor for the Treatment of Advanced Diabetic Foot Ulcer: From Proof of Concept to Confirmation of the Efficacy and Safety of the Procedure

W. Savigne, P. López-Saura, J. Fernández-Montequín, 2011 .

Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications

P. López-Saura, J. Gavilondo-Cowley, J. Berlanga-Acosta, 2009, International wound journal.

Histological and Transcriptional Expression differences between Diabetic Foot and Pressure Ulcers

J. Berlanga-Acosta, José Suárez-Alba, Y. Mendoza-Marí, 2013 .

Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics' Impaired Healing

G. Schultz, J. Berlanga-Acosta, Marianela García-Siverio, 2012, BioMed research international.

Impacto perjudicial del exceso agudo y crónico de glucosa en células involucradas en la cicatrización: fibroblastos, miofibroblastos y células precursoras vasculares

P. López-Saura, Marianela García-Siverio, Y. Mendoza-Marí, 2012 .

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial

B. Marcheco-Teruel, Guang-Wu Chen, C. Valenzuela-Silva, 2021, The Lancet Regional Health - Americas.

Epidermal Growth Factor in Healing Diabetic Foot Ulcers: From Gene Expression to Tissue Healing and Systemic Biomarker Circulation.

J. Berlanga-Acosta, Y. Mendoza-Marí, Ariana García-Ojalvo, 2020, MEDICC review.

Type 2 Diabetes Mellitus (T2DM): Biological Overview from Pathways to Organelles and its Translation toward a Torpid Wound Healing Process

P. López-Saura, G. Guillén-Nieto, Luís Herrera-Martínez, 2013 .

Chronic Wounds with Emphasis in Diabetic Foot Ulcers

D. Armstrong, G. Schultz, J. Berlanga-Acosta, 2014, BioMed research international.

Torpid Diabetic Wound Healing: Evidence on the Role of Epigenetic Forces

J. Berlanga-Acosta, Ileydis Iglesias-Marichal, A. García, 2015 .

Increased bioavailability of IFN a 2 b modificed by chemical conjugation to a two-branched polyethyleneglycol molecule

P. López-Saura, I. García, C. Peniche, 2016 .

Open Access book

P. López-Saura, J. Fernández-Montequín, C. Valenzuela-Silva, 2017 .